Cynosure Group
GEHC icon

Cynosure Group’s GE HealthCare GEHC Stock Holding History

Cynosure Group’s Portfolio GEHC Stock Details GEHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.59M Buy
24,335
+3,690
+18% +$250K 0.22% 31
2026
Q2 		$1.32M Hold
20,645
– – 0.2% 33
2026
Q1 		$1.57M Sell
20,645
-4,344,817
-100% -$343M 0.2% 45
2025
Q4 		$46.4M Buy
4,365,462
+4,344,817
+21,045% +$339M 4.72% 5
2025
Q3 		$1.55M Hold
20,645
– – 0.17% 52
2025
Q2 		$1.53M Hold
20,645
– – 0.17% 60
2025
Q1 		$1.67M Sell
20,645
-11,727
-36% -$1.01M 0.23% 51
2024
Q4 		$2.53M Sell
32,372
-160
-0.5% -$13.6K 0.38% 35
2024
Q3 		$3.05M Buy
32,532
+11,890
+58% +$998K 0.45% 35
2024
Q2 		$1.61M Sell
20,642
-11
-0.1% -$897 0.26% 53
2024
Q1 		$1.88M Sell
20,653
-113
-0.5% -$9.4K 0.34% 41
2023
Q4 		$1.61M Buy
20,766
+17
+0.1% +$1.19K 0.29% 73
2023
Q3 		$1.41M Sell
20,749
-3,958
-16% -$288K 0.43% 54
2023
Q2 		$2.01M Buy
24,707
+15,819
+178% +$1.26M 0.6% 42
2023
Q1 		$729K Buy
+8,888
New +$635K 1.1% 23

Other funds holding GEHC

State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $31.5B AUM 27.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $111B AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $54.1B AUM 39.29% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

Cynosure Group's GEHC Position: Q3 2026 in Review

Cynosure Group increased its GE HealthCare (GEHC) stake by 18% in Q3 2026, buying an estimated $250K and bringing the position to 24,335 shares worth $1.59M. The position accounts for 0.22% of the portfolio, ranked #31.

Cynosure Group first reported a position in GEHC in Q1 2023 and has held it in 15 quarters since. The position peaked at $46.4M in Q4 2025. 926 funds tracked by Wall St. Rank hold GEHC as of Q3 2026.

  • Cynosure Group held 24,335 shares of GE HealthCare worth $1.59M as of Q3 2026.
  • Cynosure Group bought 3,690 GE HealthCare shares in Q3 2026, an estimated $250K.
  • GE HealthCare made up 0.22% of Cynosure Group's portfolio in Q3 2026, its #31 holding.
  • Cynosure Group first reported a position in GE HealthCare in Q1 2023 and has held it in 15 quarters since.
  • Cynosure Group's GE HealthCare position peaked at $46.4M in Q4 2025.
  • 926 funds tracked by Wall St. Rank held GE HealthCare as of Q3 2026.

Based on Cynosure Group's 13F filing for Q3 2026, filed 3 Nov 2026.